Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Operating Expenses (2020 - 2025)

Historic Operating Expenses for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to $7.1 million.

  • KORU Medical Systems' Operating Expenses rose 352.67% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.4 million, marking a year-over-year increase of 445.65%. This contributed to the annual value of $27.8 million for FY2024, which is 296.47% up from last year.
  • Latest data reveals that KORU Medical Systems reported Operating Expenses of $7.1 million as of Q3 2025, which was up 352.67% from $6.8 million recorded in Q2 2025.
  • KORU Medical Systems' 5-year Operating Expenses high stood at $7.3 million for Q1 2025, and its period low was $4.6 million during Q2 2021.
  • Its 5-year average for Operating Expenses is $6.5 million, with a median of $6.7 million in 2022.
  • Data for KORU Medical Systems' Operating Expenses shows a peak YoY increase of 7173.46% (in 2021) and a maximum YoY decrease of 2273.09% (in 2021) over the last 5 years.
  • Over the past 5 years, KORU Medical Systems' Operating Expenses (Quarter) stood at $5.9 million in 2021, then increased by 10.84% to $6.6 million in 2022, then fell by 0.93% to $6.5 million in 2023, then increased by 9.56% to $7.2 million in 2024, then decreased by 0.28% to $7.1 million in 2025.
  • Its Operating Expenses was $7.1 million in Q3 2025, compared to $6.8 million in Q2 2025 and $7.3 million in Q1 2025.